Haruki Tomohiro, Yurugi Yohei, Wakahara Makoto, Matsuoka Yuki, Miwa Ken, Araki Kunio, Taniguchi Yuji, Nakamura Hiroshige
Division of General Thoracic Surgery, Department of Surgery, Faculty of Medicine, Tottori University, 36-1 Nishi-cho, Yonago, Tottori, 683-8504, Japan.
Surg Today. 2017 Jun;47(6):718-725. doi: 10.1007/s00595-016-1427-0. Epub 2016 Oct 3.
We investigated the efficiency of the Simplified Comorbidity Score (SCS) for predicting postoperative complications and prognosis in elderly patients undergoing video-assisted thoracoscopic surgery (VATS) for lung cancer.
We reviewed 216 patients aged 75 years or older, who underwent pulmonary resection by VATS for lung cancer between January, 2005 and December, 2012. The SCS assigns different scores to patients' comorbidities; namely, smoking (n = 7); diabetes mellitus (n = 5); renal insufficiency (n = 4); and respiratory, neoplastic, and cardiovascular comorbidities or alcoholism (n = 1 each). Patients were divided into a high SCS group (SCS ≥ 9; n = 154) and a low SCS group (<9; n = 62), for a comparative analysis of differences in perioperative factors and prognoses.
Limited resection was more frequent in the high SCS group (58 %) than in the low SCS group (40 %; P = 0.02). Postoperative complications were more frequent in the high SCS group (45 %) than in the low SCS group (15 %; P < 0.01). A logistic regression analysis revealed that a high SCS was significantly predictive of postoperative complications (odds ratio 2.7; P = 0.02). The 5-year overall survival rate was 79 % for the low SCS group and 52 % for the high SCS group (P < 0.01).
The SCS can predict the likelihood of postoperative complications and prognosis of elderly patients with VATS-treated lung cancers.
我们研究了简化合并症评分(SCS)在预测老年肺癌患者行电视辅助胸腔镜手术(VATS)后并发症及预后方面的有效性。
我们回顾了2005年1月至2012年12月期间216例年龄在75岁及以上、因肺癌接受VATS肺切除术的患者。SCS对患者的合并症赋予不同分数;即吸烟(n = 7);糖尿病(n = 5);肾功能不全(n = 4);以及呼吸、肿瘤和心血管合并症或酗酒(各n = 1)。患者被分为高SCS组(SCS≥9;n = 154)和低SCS组(<9;n = 62),以比较分析围手术期因素和预后的差异。
高SCS组(58%)比低SCS组(40%;P = 0.02)更频繁地进行有限切除。高SCS组(45%)比低SCS组(15%;P < 0.01)术后并发症更频繁。逻辑回归分析显示,高SCS显著预测术后并发症(优势比2.7;P = 0.02)。低SCS组的5年总生存率为79%,高SCS组为52%(P < 0.01)。
SCS可以预测老年VATS治疗肺癌患者术后并发症的可能性及预后。